- •Contents
- •General Introduction
- •Objectives
- •Anatomy
- •Eyelids
- •Conjunctiva
- •Lacrimal Functional Unit
- •The Tear Film
- •Cornea
- •Sclera
- •2 Examination Techniques for the External Eye and Cornea
- •Evaluation of Vision in the Patient With an Abnormal Cornea
- •External Examination
- •Slit-Lamp Biomicroscopy
- •Direct Illumination Methods
- •Indirect Illumination Methods
- •Clinical Use
- •Stains
- •Fluorescein
- •Rose Bengal and Lissamine Green
- •Evaluation of the Tear Film and Tests of Tear Production
- •Tear Composition Assays
- •Imaging Technologies
- •Impression Cytology
- •Corneal Pachymetry
- •Measurement of Corneal Biomechanics
- •Measurement of Corneal Curvature
- •Zones of the Cornea
- •Shape, Curvature, and Power
- •Keratometry
- •Computerized Corneal Topography
- •Corneal Tomography
- •Indications
- •Ultrasound Biomicroscopy
- •Anterior Segment Optical Coherence Tomography
- •Confocal Microscopy
- •External and Slit-Lamp Photography
- •Specular Microscopy
- •Anterior Segment Fluorescein Angiography
- •Esthesiometry
- •Retinoscopy
- •3 Clinical Approach to Ocular Surface Disorders
- •Common Clinical Findings
- •Conjunctival Signs
- •Corneal Signs
- •Clinical Approach to Dry Eye
- •Mechanisms of Dry Eye
- •Aqueous Tear Deficiency
- •Evaporative Dry Eye
- •Treatment of Dry Eye
- •Rosacea
- •Seborrheic Blepharitis
- •Staphylococcal Blepharitis
- •Hordeola and Chalazia
- •Exposure Keratopathy
- •Floppy Eyelid Syndrome
- •Superior Limbic Keratoconjunctivitis
- •Recurrent Corneal Erosion
- •Neurotrophic Keratopathy and Persistent Corneal Epithelial Defects
- •Trichiasis and Distichiasis
- •Factitious Ocular Surface Disorders
- •Dellen
- •Limbal Stem Cell Deficiency
- •Sjögren Syndrome
- •Ichthyosis
- •Ectodermal Dysplasia
- •Xeroderma Pigmentosum
- •Vitamin A Deficiency
- •4 Infectious Diseases of the External Eye: Basic Concepts and Viral Infections
- •Defense Mechanisms of the External Eye
- •Normal Ocular Flora
- •Pathogenesis of Ocular Infections
- •Virulence
- •Inoculum
- •Host Defense
- •Ocular Microbiology
- •Diagnostic Laboratory Techniques
- •Specimen Collection
- •Staining Methods
- •Virology and Viral Infections
- •DNA Viruses: Herpesviruses
- •Herpes Simplex Eye Diseases
- •Varicella-Zoster Virus Dermatoblepharitis, Conjunctivitis, and Keratitis
- •Epstein-Barr Virus Dacryoadenitis, Conjunctivitis, and Keratitis
- •Cytomegalovirus Keratitis and Anterior Uveitis
- •DNA Viruses: Adenoviruses
- •DNA Viruses: Poxviruses
- •Molluscum Contagiosum
- •Vaccinia
- •DNA Viruses: Papovaviruses
- •RNA Viruses
- •Bacteriology
- •Gram-positive Cocci
- •Gram-negative Cocci
- •Gram-positive Rods
- •Gram-negative Rods
- •Gram-positive Filaments
- •Chlamydia Species
- •Spirochetes
- •Mycology
- •Yeasts
- •Septate Filamentous Fungi
- •Nonseptate Filamentous Fungi
- •Parasitology
- •Protozoa
- •Helminths
- •Arthropods
- •Prions
- •Staphylococcal Blepharitis
- •Fungal and Parasitic Infections of the Eyelid Margin
- •Bacterial Conjunctivitis in Children and Adults
- •Parinaud Oculoglandular Syndrome
- •Microbial and Parasitic Infections of the Cornea and Sclera
- •Contact Lens–Related Infectious Keratitis
- •Bacterial Keratitis
- •Atypical Mycobacteria
- •Fungal Keratitis
- •Acanthamoeba Keratitis
- •Corneal Stromal Inflammation Associated With Systemic Infections
- •Microsporidiosis
- •Loiasis
- •Microbial Scleritis
- •6 Ocular Immunology
- •Overview of the Ocular Surface Immune Response
- •Tear Film
- •Immunoregulation of the Ocular Surface
- •Angiogenesis and Lymphangiogenesis in the Cornea
- •Tissue-Specific Patterns of Immune-Mediated Ocular Disease
- •Conjunctiva
- •Cornea
- •Sclera
- •Diagnostic Approach to Immune-Mediated Ocular Disorders
- •Immune-Mediated Diseases of the Eyelid
- •Contact Dermatoblepharitis
- •Atopic Dermatitis
- •Immune-Mediated Disorders of the Conjunctiva
- •Hay Fever Conjunctivitis and Perennial Allergic Conjunctivitis
- •Vernal Keratoconjunctivitis
- •Atopic Keratoconjunctivitis
- •Ligneous Conjunctivitis
- •Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- •Mucous Membrane Pemphigoid
- •Ocular Graft-vs-Host Disease
- •Other Immune-Mediated Diseases of the Skin and Mucous Membranes
- •Immune-Mediated Diseases of the Cornea
- •Thygeson Superficial Punctate Keratitis
- •Interstitial Keratitis Associated With Infectious Diseases
- •Reactive Arthritis
- •Cogan Syndrome
- •Marginal Corneal Infiltrates Associated With Blepharoconjunctivitis
- •Peripheral Ulcerative Keratitis Associated With Systemic Immune-Mediated Diseases
- •Mooren Ulcer
- •Corneal Transplant Rejection
- •Immune-Mediated Diseases of the Episclera and Sclera
- •Episcleritis
- •Scleritis
- •8 Clinical Approach to Neoplastic Disorders of the Conjunctiva and Cornea
- •Approach to the Patient With a Neoplastic Conjunctival Lesion
- •Management of Patients With Conjunctival Tumors
- •Surgical Treatment
- •Topical Chemotherapy
- •Tumors of Epithelial Origin
- •Benign Epithelial Tumors
- •Preinvasive Epithelial Lesions
- •Malignant Epithelial Lesions
- •Management of Atypical Epithelial Tumors
- •Other Malignant Epithelial Lesions
- •Glandular Tumors of the Conjunctiva
- •Oncocytoma
- •Sebaceous Gland Carcinoma
- •Tumors of Neuroectodermal Origin
- •Benign Pigmented Lesions
- •Preinvasive Pigmented Lesions
- •Malignant Pigmented Lesions
- •Neurogenic and Smooth-Muscle Tumors
- •Vascular and Mesenchymal Tumors
- •Benign Tumors
- •Malignant Tumors
- •Lymphatic and Lymphocytic Tumors
- •Lymphangiectasia and Lymphangioma
- •Lymphoid Hyperplasia
- •Lymphoma
- •Metastatic Tumors
- •9 Basic and Clinical Concepts of Congenital Anomalies of the Cornea, Sclera, and Globe
- •Developmental Anomalies of the Globe and Sclera
- •Cryptophthalmos
- •Microphthalmos
- •Nanophthalmos
- •Blue Sclera
- •Developmental Anomalies of the Anterior Segment
- •Anomalies of Size and Shape of the Cornea
- •Abnormalities of Corneal Structure and/or Clarity
- •Secondary Abnormalities Affecting the Fetal Cornea
- •Intrauterine Keratitis: Bacterial and Syphilitic
- •Congenital Corneal Keloid
- •Congenital Corneal Anesthesia
- •Congenital Glaucoma
- •Birth Trauma
- •Arcus Juvenilis
- •10 Corneal Dystrophies and Ectasias
- •Corneal Dystrophies
- •Epithelial and Subepithelial Dystrophies
- •Bowman Layer Corneal Dystrophies
- •Stromal Corneal Dystrophies: TGFBI Dystrophies
- •Stromal Dystrophies: Non-TGFBI Dystrophies
- •Endothelial Dystrophies
- •Ectatic Disorders
- •Keratoconus
- •Pellucid Marginal Degeneration
- •Keratoglobus
- •11 Systemic Disorders With Corneal Changes
- •Disorders of Carbohydrate Metabolism
- •Mucopolysaccharidoses
- •Diabetes Mellitus
- •Disorders of Lipid Metabolism and Storage
- •Hyperlipoproteinemias
- •Hypolipoproteinemias
- •Sphingolipidoses
- •Mucolipidoses
- •Disorders of Amino Acid Metabolism
- •Cystinosis
- •Tyrosinemia
- •Alkaptonuria
- •Disorders of Protein Metabolism
- •Amyloidosis
- •Disorders of Immunoglobulin Synthesis
- •Noninflammatory Disorders of Connective Tissue
- •Ehlers-Danlos Syndrome
- •Marfan Syndrome
- •Disorders of Nucleotide Metabolism
- •Gout
- •Porphyria
- •Disorders of Mineral Metabolism
- •Wilson Disease
- •Hypercalcemia
- •Hemochromatosis
- •Corneal and External Disease Signs of Systemic Neoplasia
- •Enlarged Corneal Nerves
- •Appendix
- •12 Clinical Approach to Depositions and Degenerations of the Conjunctiva, Cornea, and Sclera
- •Degenerative Changes of the Conjunctiva
- •Age-Related (Involutional) Changes
- •Pinguecula
- •Pterygium
- •Conjunctival Concretions
- •Conjunctival Inclusion Cysts
- •Conjunctivochalasis
- •Conjunctival Vascular Tortuosity and Hyperemia
- •Degenerative Changes in the Cornea
- •Age-Related (Involutional) Changes
- •Epithelial and Subepithelial Degenerations
- •Stromal Degenerations
- •Endothelial Degenerations
- •Scleral Degenerations
- •Drug-Induced Deposition and Pigmentation
- •Corneal Epithelial Deposits
- •Stromal and Descemet Membrane Pigmentation
- •Endothelial Manifestations
- •13 Clinical Aspects of Toxic and Traumatic Injuries of the Anterior Segment
- •Injuries Caused by Temperature and Radiation
- •Thermal Burns
- •Ultraviolet Radiation
- •Ionizing Radiation
- •Chemical Injuries
- •Alkali Burns
- •Acid Burns
- •Management of Chemical Injuries
- •Toxic Keratoconjunctivitis From Medications
- •Pathogenesis
- •Clinical Presentation
- •Management
- •Animal and Plant Substances
- •Insect Injuries
- •Vegetation Injuries
- •Concussive Trauma
- •Subconjunctival Hemorrhage
- •Corneal Changes
- •Traumatic Mydriasis and Miosis
- •Traumatic Iritis
- •Iridodialysis and Cyclodialysis
- •Traumatic Hyphema
- •Nonperforating Mechanical Trauma
- •Conjunctival Laceration
- •Conjunctival Foreign Body
- •Corneal Foreign Body
- •Corneal Abrasion
- •Perforating Trauma
- •Evaluation
- •Management
- •Surgical Trauma
- •Corneal Epithelial Changes From Intraocular Surgery
- •Descemet Membrane Changes During Intraocular Surgery
- •Corneal Endothelial Changes From Intraocular Surgery
- •Conjunctival and Corneal Changes From Extraocular Surgery
- •14 Treatment of Ocular Surface Disorders
- •Surgical Procedures of the Ocular Surface
- •Limbal Transplantation
- •Autologous Conjunctival Transplantation
- •Pterygium Excision
- •Mucous Membrane Grafting
- •Conjunctival Flap
- •Conjunctival Biopsy
- •Conjunctivochalasis Excision
- •Therapeutic Interventions for Corneal Disease
- •Superficial Keratectomy and Corneal Biopsy
- •Management of Descemetocele, Corneal Perforation, and Corneal Edema
- •Corneal Tattoo
- •Tarsorrhaphy
- •15 Clinical Approach to Corneal Transplantation
- •Corneal Transplantation
- •Eye Banking and Donor Selection
- •Criteria Contraindicating Donor Cornea Use
- •Surgical Approach to Corneal Disease
- •Preoperative Evaluation and Preparation
- •Penetrating Keratoplasty
- •Surgical Technique for Penetrating Keratoplasty
- •Combined Procedures
- •Intraoperative Complications
- •Postoperative Care and Complications
- •Control of Postoperative Corneal Astigmatism and Refractive Error
- •Diagnosis and Management of Graft Rejection
- •Pediatric Corneal Transplantation
- •Corneal Autograft Procedures
- •Keratoprosthesis
- •Lamellar Keratoplasty
- •Anterior Lamellar Transplantation
- •Surgical Technique
- •Postoperative Care and Complications
- •Endothelial Keratoplasty
- •DSEK Surgical Technique and Complications
- •Descemet Membrane Endothelial Keratoplasty
- •Basic Texts
- •Related Academy Materials
- •Requesting Continuing Medical Education Credit
Figure 3-25 Topical anesthetic overuse with persistent corneal epithelial defect and necrotic ring opacity. (Courtesy of Kirk R.
Wilhelmus, MD.)
Differential diagnosis includes bacterial, fungal, herpetic, and amebic keratitis. Suspicion should be maintained in the face of negative cultures in any patient who is not responding to appropriate therapy. Often, the diagnosis is made only when the patient is discovered concealing the anesthetic drops. Once the diagnosis is made and infectious keratitis is ruled out, corneal healing usually occurs if all exposure to anesthetics is removed. In advanced cases, permanent corneal scarring or perforation may occur. Psychiatric counseling is sometimes helpful.
Dellen
Desiccation of the epithelium and subepithelial tissues occurs at or near the limbus adjacent to surface elevations such as those produced by pterygia, large filtration blebs, or dermoids. Because the tear film is interrupted by these surface elevations, normal blinking does not wet the involved area properly. Clinically, dellen are saucerlike depressions in the corneal surface. The epithelium exhibits punctate irregularities overlying a thinned area of dehydrated corneal stroma. Treatment with frequent ocular lubrication or pressure patching accelerates the healing process and restores stromal hydration.
The orbital and conjunctival tissues surrounding the sclera also play a role in maintaining scleral hydration. This function becomes especially evident during surgical procedures in which the conjunctiva and extraocular muscles are removed from the scleral surface. The exposed sclera becomes thinner and partially translucent unless it is continually remoistened. Removal of the perilimbal conjunctiva and interference with the wetting effect of the tear film (as after excision of a pterygium using the bare sclera technique) can cause the underlying sclera to become markedly thinned and translucent, forming a scleral delle.
Limbal Stem Cell Deficiency
PATHOGENESIS The ocular surface is composed of permanently renewing populations of epithelial cells. These epithelial cells are replaced through proliferation of a distinct subpopulation of cells known as stem cells. Corneal stem cells are located in the basal cell layer of the limbus, whereas conjunctival stem cells may be uniformly distributed throughout the bulbar surface or located in the fornices. Stem cells have an unlimited capacity for self-renewal and are slow cycling (ie, they have low mitotic activity). Once stem cell differentiation begins, it is irreversible. The process of differentiation occurs by means of transit amplification. Transit-amplifying cells, which have a limited capacity for self-renewal, can be found at the limbus as well as at the basal layer of the corneal epithelium. Each of these cells is able to undergo a finite number of cell divisions. Corneal and conjunctival stem cells can be identified only by indirect means, such as clonal expansion and identification of slow cycling.
Approximately 25%–33% of the limbus must be intact to ensure normal ocular resurfacing. The normal limbus acts as a barrier against corneal vascularization from the conjunctiva and invasion of conjunctival cells from the bulbar surface. When the limbal stem cells are congenitally absent, injured, or destroyed, conjunctival cells migrate onto the ocular surface, often accompanied by superficial neovascularization. The absence of limbal stem cells reduces the effectiveness of epithelial wound healing, as evidenced by compromised ocular surface integrity with an irregular
ocular surface and recurrent epithelial breakdown.
See Table 3-11 for an etiologic classification of limbal stem cell deficiency.
Table 3-11
CLINICAL PRESENTATION Clinically, stem cell deficiency of the cornea can be observed in several ocular surface disorders. Patients usually have recurrent ulceration and decreased vision as a result of the irregular corneal surface. Corneal neovascularization is invariably present in the involved cornea. A wavelike irregularity of the ocular surface emanating from the limbus can be more easily observed following the instillation of topical fluorescein (Fig 3-26). In some cases, increased epithelial permeability can be observed clinically by diffuse permeation of topical fluorescein into the anterior stroma.
Figure 3-26 Mild stem cell deficiency secondary to contact lens usage. A wavelike irregularity of the ocular surface is seen following instillation of topical fluorescein. (Courtesy of James J. Reidy, MD.)
Stem cell deficiency states result from both primary and secondary causes. Primary causes include PAX6 gene mutations (aniridia), ectrodactyly–ectodermal dysplasia–clefting syndrome, sclerocornea, keratitis-ichthyosis-deafness (KID) syndrome, and congenital erythrokeratodermia. Secondary causes include chemical burns, thermal burns, radiation, contact lens wear, ocular surgery, mucous membrane conjunctivitis (eg, mucous membrane pemphigoid, trachoma, Stevens-Johnson syndrome), pterygia, use of topical medications (pilocarpine, β-blockers, antibiotics, antimetabolites), and dysplastic or neoplastic lesions of the limbus.
MANAGEMENT In mild or focal cases associated with local factors such as contact lens use or topical medications, any possible inciting cause should be discontinued. In these cases, treatment with topical steroids may be helpful. If the stem cell deficiency is sectoral and mild, the abnormal epithelium can be debrided, allowing for resurfacing of the denuded area with cells derived from the remaining intact limbal epithelium.
In more extensive or severe cases of limbal stem cell deficiency, initial therapy with a scleral contact lens may be helpful. If this is not effective, replacement of stem cells by limbal transplantation is an alternative. When the limbus is focally affected in 1 eye, as with a pterygium, a limbal or conjunctival autograft can be harvested from the ipsilateral eye. For unilateral, moderate or severe chemical injuries, a limbal autograft can be obtained from the healthy fellow eye. For bilateral limbal deficiency, as with Stevens-Johnson syndrome or bilateral chemical burns, a limbal allograft from a human leukocyte antigen–matched living related donor (or, if unavailable, an eye bank donor eye)
can be considered; however, systemic immune suppression is required following limbal allograft transplantation (see the discussion of ocular surface surgery in Chapter 14). Another alternative in cases of severe limbal cell deficiency is a keratoprosthesis (see Chapter 15).
Schwartz GS, Holland EJ. Classification and staging of ocular surface disease. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. 3rd ed. Vol 2. Philadelphia: Elsevier/Mosby; 2011:1713–1720.
Systemic Conditions Associated With Ocular Surface
Disorders
Sjögren Syndrome
Patients with ATD are considered to have Sjögren syndrome if they have associated hypergammaglobulinemia, rheumatoid arthritis, or circulating autoantibodies. The revised international classification criteria for Sjögren syndrome appear in Table 3-12. Although the precise causes of ATD in Sjögren syndrome are unknown, it is generally considered to be a T-cell–mediated inflammatory disease leading to destruction of the lacrimal glands, in part by increasing the rate of programmed cell death.
Table 3-12
Involvement of the salivary glands is common, resulting in dry mouth and predisposing the patient to periodontal disease. Mucous membranes throughout the body (ie, vaginal, gastric, and respiratory mucosae) may be affected, greatly affecting the patient’s quality of life.
Sjögren syndrome can be divided into 2 clinical subsets. Primary Sjögren syndrome includes patients who either have ill-defined systemic immune dysfunction or lack any evidence of immune dysfunction or connective tissue disease. Secondary Sjögren syndrome occurs in patients with a welldefined, generalized connective tissue disease. It is most commonly associated with rheumatoid arthritis; however, many other autoimmune and systemic diseases are frequently encountered (Table 3-13).
Table 3-13
